2009 34st Congress ESMO a 15th Congress ECCO - účast ČR

Poster session II: Genitourinary malignancies - Other

Extragonadal germ cell tumours - results from a single centre

Autoři: prof. MUDr. Tomáš Büchler, Ph.D.; MUDr. Martin Foldyna; MUDr. Jana Nepomucká, CSc.; MUDr. Zuzana Donátová; MUDr. Martin Kupec; prof. MUDr. Jitka Abrahámová, DrSc.
Číslo abstraktu: P-7179
Kategorie: Genitourinární nádory

Poster session II: Genitourinary malignancies - Renal cancer

Bevacizumab (BEV) and interferon (IFN) therapy does not increase risk of cardiac events in metastatic renal cell carcinoma (mRCC)

Autoři: MD Joaquim Bellmunt; prof. MUDr. Bohuslav Melichar, Ph.D.; Sergio Bracarda; S.N. Negrier; Prof. MD Alain Ravaud, PhD; R. Laeufle; V. Sneller; MD Bernard J. Escudier
Číslo abstraktu: P-7121
Kategorie: Genitourinární nádory

First-line bevacizumab + reduced-dose interferon-alpha2a in patients (pts) with metastatic renal cell carcinoma (mRCC): an update on overall survival

Autoři: prof. MUDr. Bohuslav Melichar, Ph.D.; Sergio Bracarda; MD Joaquim Bellmunt; Prof. MD Alain Ravaud, PhD; S.N. Negrier; S. Jethwa; MD Bernard J. Escudier
Číslo abstraktu: P-7123
Kategorie: Genitourinární nádory

What is the impact of subsequent antineoplastic therapy on overall survival (OS) following first-line bevacizumab (BEV)/interferon-alpha2a (IFN) in metastatic renal cell carcinoma (mRCC)? - Experience from AVOREN

Autoři: Sergio Bracarda; MD Joaquim Bellmunt; S.N. Negrier; prof. MUDr. Bohuslav Melichar, Ph.D.; Prof. MD Alain Ravaud, PhD; S. Jethwa; V. Sneller; MD Bernard J. Escudier
Číslo abstraktu: P-7126
Kategorie: Genitourinární nádory

PREDICT (Patient characteristics in Renal cell carcinoma and Daily practice Treatment with Nexavar) global non-interventional study: first interim results

Autoři: Prof. Dr. Dirk Jäger; J.H. Ma; MD Ernesto Korbenfeld; Doc. MUDr. Milada Zemanová, Ph.D.; Nicolai Leonhartsberger; Kathrin Stauch; A. Bockenhoff; J. Yu; MD Bernard J. Escudier
Číslo abstraktu: P-7128
Kategorie: Genitourinární nádory

Poster Session III: Diagnostic/Biomarkers

The prognostic impact of serum angiogenic factors in renal cell carcinoma

Autoři: doc. MUDr. Otakar Kopecký, CSc.; MUDr. Šárka Lukešová, Ph.D.; MUDr. Dagmar Hlávková, Ph.D.; Mgr. Vladimíra Vroblová, Ph.D.; Doc.RNDr. Ctirad Andrýs, Ph.D.; MUDr. Petr Morávek, CSc.; RNDr. Eva Čermáková, CSc.
Číslo abstraktu: P-1336
Kategorie: Genitourinární nádory

Poster Session III: Head and neck cancer

A phase 2 randomized trial of radiotherapy (RT) plus panitumumab compared to chemoradiotherapy in patients with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): interim pooled safety analysis

Autoři: J. Giralt; J.M. Trigo; S. Nuyts; M. Ozsahin; A.B. Markowitz; J. Daisne; K. Skladowski; C. Lonchay; Mgr. et MUDr. Petra Holečková, Ph.D., MBA; M. Smitt
Číslo abstraktu: P-8516
Kategorie: Nádory hlavy a krku

Poster Session IV: Symptom science

G-CSF use and neutropenic events in patients with breast and lung tumours: data from routine clinical practice (IMPACT Solid study)

Autoři: K. Krzemieniecki; F.L.G. Erdkamp; H. Lindman; J. Maenpaa; J. Puertas; M. Schwenkglenks; P. Sevelda; MUDr. Martin Šmakal; I. Varthalitis; S. Verma
Číslo abstraktu: P-3036
Kategorie: Zhoubné nádory prsu

Poster Session V: Gastro-intestinal malignancies - colorectal cancer

Presence of KRAS and BRAF oncogenic mutations sensitise colorectal tumours to TRAIL induced apoptosis: evidence from cell and animal models translated to the clinic

Autoři: A. Pintzas; E. Oikonomou; RNDr. Ladislav Anděra, CSc.; G. Zografos; G. Kontogeorgos; V. Kosmidou
Číslo abstraktu: P-6126
Kategorie: Kolorektální karcinom

Poster session V: Lung cancer

Analysis of treatment effects of erlotinib in non small cell lung cancer patients

Autoři: MUDr. Lenka Jakubíková, Ph.D.; MUDr. Marcela Tomíšková; prof. MUDr. Jana Skřičková, CSc.; B. Kaldec; MUDr. Jana Kaplanová; RNDr. Tomáš Pavlík, Ph.D.
Číslo abstraktu: P-9133
Kategorie: Zhoubné nádory plic a průdušek

Poster Session VI: Breast cancer - Clinical advanced disease

High efficacy of the combination of oral vinorelbine (NVBo), capecitabine (X) and trastuzumab (H) in HER2-positive metastatic breast cancer (MBC): updated results of an international phase II trial with a median follow-up of 39 months

Autoři: A. T. C. Chan; V. Ganju; D. Becquart; P.F. Conte; prof. MUDr. Luboš Petruželka, CSc.; M. Gil-Gil; M. Morand; Nathalie Vaissiere; G. Villanova; N. Tubiana-Mathieu
Číslo abstraktu: P-5055
Kategorie: Zhoubné nádory prsu

Poster Session VII: Paediatric Oncology

Hypersensitivity reactions and other complications due to Lasparaginase in the treatment of acute lymphoblastic leukemia according to ALL IC 2002 protocol

Autoři: MUDr. Lucie Hrdličková; MUDr. Petr Říha; MUDr. Petr Smíšek; Mgr. Iveta Janotová; prof. MUDr. Jan Starý, DrSc.
Číslo abstraktu: P-4119
Kategorie: Maligní lymfomy a leukémie

Presidential session

Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated vs conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)

Autoři: M. Baumann; T. Herrmann; R. Koch; B. Wahlers; L. Kepka; G. Marschke; Prof. MUDr. David Feltl, Ph.D., MBA; R. Fietkau; V. Budach; J. Dunst
Číslo abstraktu: 4LBA
Kategorie: Zhoubné nádory plic a průdušek

Proffered paper session: Genitourinary malignancies - Prostate cancer

A double blind, randomised, dose finding, phase II, multicentre study of radium-223 for the treatment of patients with metastatic castration-refractory prostate cancer (CRPC): EudraCT number: 2005-003680-22

Autoři: C. Parker; P. Hoskin; S. Pascoe; A. Chodack; J.M. O'Sullivan; J.R. Germá; A. Lokna
Číslo abstraktu: O-7003
Kategorie: Genitourinární nádory